News

Publicis Touchpoint Solutions does a deal with Cegedim Relationship Management

Internal compliance reviews are not enough; life sciences companies need to assess their third-party business partners

Defining 'market access'

Compliance issues around sampling will be featured at upcoming conference

Details will come out later on what the new initiative entails

While traditional retail chains still dominate, the focus by PBMs on specialty distribution is raising their presence among top retailers

Industry 'Firepower Index' shows increased capacity for deal-making, but specialty pharma is pushing Big Pharma to the side

Survey of construction projects and facility upgrads finds 739 projects initiated

Key oncolytics will require cold chain storage; room-temp products still have varying temperature requirements

Publicis Touchpoint, a leading CSO, does a deal with Cegedim Relationship Management

Company hires Kevin O'Donnell, cold-chain expert, to build out its Biologistex shipping service

Acquisition builds on Dohmen's rare-disease business

Mapi Group casts itself as a leading 'health research and commercialization' player

So long WAG, hello to WBA as pharma manufacturers look at a consolidating buyer landscape

Enforcement actions are postponed to May 1 under new guidance

Express Scripts touts a 'fundamental change' in drug pricing; others would call it negotiating a discount

Pharmacists' ranking, continuing a two-year decline, is now neck-and-neck with doctors

Poltraf acquisition adds to a network of 14 facilities serving Eastern and Western Europe

Annual award promotes patient-adherence aspects of unit-dose packaging

'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney

Orphan drug approvals, at 15 so far, sets a record

DSCSA's Jan 1 deadline is the immediate worry, says HDMA

FDA issues guidance for filings from such organizations under the Drug Supply Chain Security Act (DSCSA)

New operations center at JFK airport for Marken; new distribution center in Texas for BDI

Cargo, logistics and packaging interests are represented

GPhA 'applauds' the guidance for Risk Evaluation and Mitigation Strategies (REMS) programs

Consolidation creates a global pharma distributor grossing $170 billion and employing 85,000